Literature DB >> 2819446

Retinal ganglion cell degeneration in Alzheimer's disease.

J C Blanks1, D R Hinton, A A Sadun, C A Miller.   

Abstract

This study documents the light-microscopic and ultrastructural characteristics of ganglion cell degeneration in the retinas of patients with Alzheimer's disease (AD). The results show degeneration in the retinal ganglion cells (RGCs) characterized by a vacuolated, 'frothy' appearance of the cytoplasm. The degeneration is unique in AD because of the absence of neurofibrillary tangles within the RGCs, or of neuritic plaques or amyloid angiopathy in the retinas or optic nerves of any of the cases examined. These results suggest that neuronal degeneration in the ganglion cell layer (GCL) should be added to the constellation of neuropathologic changes found in patients with Alzheimer's disease.

Entities:  

Mesh:

Year:  1989        PMID: 2819446     DOI: 10.1016/0006-8993(89)90653-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  84 in total

1.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

2.  Ocular changes in TgF344-AD rat model of Alzheimer's disease.

Authors:  Yuchun Tsai; Bin Lu; Alexander V Ljubimov; Sergey Girman; Fred N Ross-Cisneros; Alfredo A Sadun; Clive N Svendsen; Robert M Cohen; Shaomei Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 3.  At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Authors:  Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

4.  Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Malia M Edwards; José J Rodríguez; Raquel Gutierrez-Lanza; Joseph Yates; Alexei Verkhratsky; Gerard A Lutty
Journal:  Exp Eye Res       Date:  2014-08-19       Impact factor: 3.467

5.  Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials.

Authors:  F Sartucci; D Borghetti; T Bocci; L Murri; P Orsini; V Porciatti; N Origlia; L Domenici
Journal:  Brain Res Bull       Date:  2010-04-10       Impact factor: 4.077

6.  Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study.

Authors:  Unal Mutlu; Johanna M Colijn; M Arfan Ikram; Pieter W M Bonnemaijer; Silvan Licher; Frank J Wolters; Henning Tiemeier; Peter J Koudstaal; Caroline C W Klaver; M Kamran Ikram
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

7.  Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease.

Authors:  D C Davies; P McCoubrie; B McDonald; K A Jobst
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

8.  Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Authors:  Bingqian Liu; Suhail Rasool; Zhikuan Yang; Charles G Glabe; Steven S Schreiber; Jian Ge; Zhiqun Tan
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

9.  Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.

Authors:  Cheng-Ying Ho; Juan C Troncoso; David Knox; Walter Stark; Charles G Eberhart
Journal:  Brain Pathol       Date:  2013-06-28       Impact factor: 6.508

10.  Association of apolipoprotein E-219T>G promoter polymorphism with primary open angle glaucoma in Turkish population.

Authors:  Emel Saglar; Banu Bozkurt; Murat Irkec
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.